newsfilter
← Latest News
Business Wire·

4D pharma to Present at the Microbiome Movement Drug Development Summit

4D pharma plc ((AIM: DDDD, NASDAQ:LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome, today announces Christophe Carite, Development Director, will deliver a